Increased GLP-1 response after gavage-administration of glucose in UCP2-deficient Mice

Hormone and Metabolic Research

Volumn 44, Issue 2, 2012, Pages 86-90

  Zhang, H ^a   Li, J ^b   Li, Z ^a   Luo, Y ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

GLP 1; glucose; gut; UCP2; UCP2 deficient mice

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; MESSENGER RNA; UNCOUPLING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDING; GASTROINTESTINAL TRACT; GLUCOSE BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; GASTROINTESTINAL TRACT; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TOLERANCE TEST; ION CHANNELS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIAL PROTEINS; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MUS;

EID: 84857045332     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1298017     Document Type: Article

References (31)

1. Elrick H, Stimmler L, Hlad C J Jr, Arai Y. Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab: 1964; 24 1076 1082
2. McIntyre N, Holdsworth C D, Turner D S. Intestinal factors in the control of insulin secretion. J Clin Endocrinol Metab: 1965; 25 1317 1324
3. Perley M J, Kipnis D M. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest: 1967; 46 1954 1962
4. Ranganath L, Schaper F, Gama R, Morgan L, Wright J, Teale D. Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1). Diabetes Metab Res Rev: 1999; 15 390 394 (Pubitemid 30066225)
5. Holst J J, rskov C, Vagn Nielsen O, Schwartz T W. Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett: 1987; 211 169 174 (Pubitemid 17049446)
6. Eissele R, Göke R, Willemer S, Harthus H P, Vermeer H, Arnold R, Göke B. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig, and man. Eur J Clin Invest: 1992; 22 283 291
7. Larsson L I, Holst J, Hakanson R, Sundler F. Distribution and properties of glucagon immuno-reactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study. Histochemistry: 1975; 44 281 290
8. Damholt A B, Kofod H, Buchan A M. Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine. Cell Tissue Res: 1999; 298 287 293 (Pubitemid 29512080)
9. Toft-Nielsen M B, Damholt M B, Madsbad S, Hilsted L M, Hughes T E, Michelsen B K, Holst J J. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab: 2001; 86 3717 3723 (Pubitemid 32755966)
10. Edwards C M, Todd J F, Mahmoudi M, Wang Z, Wang R M, Ghatei M A, Bloom S R. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes: 1999; 48 86 93 (Pubitemid 29019356)
11. Tseng C C, Zhang X Y, Wolfe M M. Effect of GIP and GLP-1 antagonists on insulin release in the rat. Am J Physiol: 1999; 276 6 Pt 1 E1049 E1054 (Pubitemid 29323420)
12. Rorsman P. The pancreatic -cell as a fuel sensor: an electrophysiologists viewpoint. Diabetologia: 1997; 40 487 495 (Pubitemid 27186783)
13. Simpson A K, Ward P S, Wong K Y, Collord G J, Habib A M, Reimann F, Gribble F M. Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line. Diabetologia: 2007; 50 2181 2189 (Pubitemid 47373843)
14. Herrmann C, Göke R, Richter G, Fehmann H C, Arnold R, Göke B. Glucagon-like peptide-1 and glucose dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion: 1995; 56 117 126
15. Ritzel U, Fromme A, Ottleben M, Leonhardt U, Ramadori G. Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Acta Diabetol: 1997; 34 18 21 (Pubitemid 27173979)
16. Gribble F M, Williams L, Simpson A K, Reimann F. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes: 2003; 52 1147 1154 (Pubitemid 36523349)
17. Margolskee R F, Dyer J, Kokrashvili Z, Salmon K S, IIegems E, Daly K, Maillet E L, Ninomiya Y, Mosinger B, Shirazi-Beechey S P. T1R3 and gustducin in gut sense sugars to regulate expression of Na+glucose cotransporter1. Proc Natl Acad Sci USA: 2007; 104 15075 15080 (Pubitemid 47619595)
18. Rozengurt E, Sternini C. Taste receptor signaling in the mammalian gut. Curr Opin Pharmacol: 2007; 7 557 562 (Pubitemid 350185856)
19. ATP channel) expression in the normal canine pancreas and in canine insulinomas. BMC Vet Res: 2005; 1 8
20. Nielsen L B, Ploug K B, Swift P, rskov C, Jansen-Olesen I, Chiarelli F, Holst J J, Hougaard P, Pörksen S, Holl R, de Beaufort C, Gammeltoft S, Rorsman P, Mortensen H B, Hansen L. Hvidre Study Group. Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes. Eur J Endocrinol: 2007; 156 663 671 (Pubitemid 46952536)
21. Jezek P. Possible physiological roles of mitochondrial uncoupling proteins - UCPn. Int J Biochem Cell Biol: 2002; 34 1190 1206 (Pubitemid 34804355)
22. Diao J, Allister E M, Koshkin V, Lee S C, Bhattacharjee A, Tang C, Giacca A, Chan C B, Wheeler M B. UCP2 is highly expressed in pancreatic-cells and influences secretion and survival. Proc Natl Acad Sci USA: 2008; 105 12057 12062
23. Nedergaard J, Cannon B. The novel uncoupling proteins UCP2 and UCP3: what do they really do? Pros and cons for suggested functions. Exp Physiol: 2003; 88 65 84 (Pubitemid 36150060)
24. Mattiasson G, Sullivan P G. The emerging functions of UCP2 in health, disease, and therapeutics. Antioxid Redox Signal: 2006; 8 1 38 (Pubitemid 43324527)
25. Ahrn B, Larsson H, Holst J J. Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose tolerance. Eur J Endocrinol: 1997; 137 127 131 (Pubitemid 27342226)
26. Ahrn B. Glucagon-like peptide 1 (GLP-1) - a gut hormone of potential interest in the treatment of diabetes. Bioessays: 1998; 20 642 651
27. Zhang C Y, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig A J, Boss O, Kim Y B, Zheng X X, Wheeler M B, Shulman G I, Chan C B, Lowell B B. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell: 2001; 105 745 755 (Pubitemid 32635104)
28. Theodorakis M J, Carlson O, Michopoulos S, Doyle M E, Juhaszova M, Petraki K, Egan J M. Human duodenal enteroendocrine cells: source of both incretions peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab: 2006; 290 E550 E559 (Pubitemid 43671703)
29. Schirra J, Katschinski M, Weidmann C, Schäfer T, Wank U, Arnold R, Göke B. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest: 1996; 97 92 103 (Pubitemid 26021698)
30. Balks H J, Holst J J, von zur Mühlen A, Brabant G. Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. J Clin Endocrinol Metab: 1997; 82 786 790 (Pubitemid 27106588)
31. Kim B J, Carlson O D, Jang H J, Elahi D, Berry C, Egan J M. Peptide YY is secreted after oral glucose administration in a gender-specific manner. J Clin Endocrinol Metab: 2005; 90 6665 6671 (Pubitemid 41759330)